In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, to discuss recent outbreaks in vaccine-preventable diseases.

Specific topics of discussion include:

• Recent increases in outbreaks of infectious diseases, such as pertussis, measles, and polio.
• The serious side effects of the diseases.
• What’s fueling the resurgence of these diseases.
• Testing options for infectious diseases and resources for physicians.

While confirmed cases for many respiratory illnesses are currently low, they will almost certainly spread as we move further into fall and winter. Now is the perfect time to prepare and take steps to protect yourself from everything from COVID-19 and influenza to RSV and the common cold.

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, to discuss practical steps for protecting yourself and innovations that are making testing and vaccination easier.

Specific topics of discussion include:

• The importance of vaccinations and preventive measures to keep you healthy.
• Innovations that are making it possible to provide more at-home options for vaccination and testing and when these options will be most beneficial.
• The latest status on avian influenza.

Megan Hoenig, M.S., M.P.H., CGC, explains how Mayo Clinic Laboratories' unique hypermethylation analysis (Mayo ID: MLHPB) provides critical adjunct information for managing Lynch syndrome. That genetic condition increases patients' risk for many kinds of cancer.

Speaker 3: (00:32)
Could you provide our listeners with a little bit about yourself and your background?

Speaker 3: (01:27)
Could you give an overview of our MLH1 hypermethylation, also referred to as MLHPB in our test catalog?

Speaker 3: (02:48)
Can you talk about why your team thought it was really important to develop this test?

Speaker 3: (04:03)
What patients would this testing really benefit?

Speaker 3: (06:10)

How are the results used in patient care?

Speaker 3: (07:56)
Anything else you would like our listeners to hear about MLHPB?